|
Keywords
|
New Drugs Botulinum Toxin Neuromodulation |
|
Target Audience
|
Urologists
Gynecologists
Physiatrists |
|
Aims and Objectives
|
To review the current status of conservative, minimal invasive and surgical treatment in the management of intractable overactive bladder symptoms. To address efficacy, mechanism of actions, technical issues, alternative and new techniques, adverse events, the cost-effectiveness, and current considerations on the use of botulinum toxin and SNM as second-line treatments in OAB.
|